Broach Lifecare Hospital Ltd () News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{
  "main_header": {
    "sid": 10039354,
    "name": "Broach Lifecare",
    "stock_name": "Broach Lifecare",
    "full_name": "Broach Lifecare Hospital Ltd",
    "name_url": "stocks-analysis/broach-lifecare",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "13.00",
    "chg": "0.00",
    "chgp": "0.00%",
    "dir": 0,
    "prev_price": "13.00",
    "mcapval": "8.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 544231,
    "symbol": "",
    "ind_name": "Hospital",
    "ind_code": 94,
    "indexname": "",
    "isin": "INE0SFZ01018",
    "curr_date": "Jan 30",
    "curr_time": "",
    "bse_nse_vol": 6000,
    "exc_status": "Active",
    "traded_date": "Jan 30, 2026",
    "traded_date_str": "2026 01 30",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://uat-researchintel.adityabirlamoney.com/ABML-Landingstocks-analysis/broach-lifecare-10039354-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "How has been the historical performance of Broach Lifecare?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/how-has-been-the-historical-performance-of-broach-lifecare-3704362",
        "imagepath": "",
        "date": "2025-11-15 00:35:57",
        "description": "Answer:\nThe historical performance of Broach Lifecare shows a mixed trend in financial metrics from March 2024 to March 2025.\n\nBreakdown:\nIn the fiscal year ending March 2025, Broach Lifecare reported net sales of 3.18 Cr, an increase from 2.61 Cr in the previous year. Total operating income also rose to 3.18 Cr from 2.61 Cr, while total expenditure increased to 2.35 Cr from 1.58 Cr. Operating profit (PBDIT) decreased to 0.88 Cr from 1.03 Cr, leading to a decline in profit before tax to 0.72 Cr from 0.93 Cr. Consequently, profit after tax fell to 0.54 Cr from 0.70 Cr. The earnings per share (EPS) dropped to 0.89 from 1.57, reflecting a decrease in profitability. On the balance sheet, shareholder's funds grew to 9.36 Cr from 5.47 Cr, and total liabilities increased to 10.92 Cr from 5.72 Cr. The company reported a cash flow from financing activities of 4.00 Cr, consistent with the previous year, while cash fl..."
      },
      {
        "title": "Is Broach Lifecare overvalued or undervalued?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-broach-lifecare-overvalued-or-undervalued-3678251",
        "imagepath": "",
        "date": "2025-11-07 08:14:28",
        "description": "As of 6 November 2025, Broach Lifecare's valuation grade has moved from very attractive to attractive, indicating a shift in market perception. The company is currently assessed as fairly valued. Key ratios include a PE Ratio of 20.23, an EV to EBITDA of 11.78, and a ROCE of 6.90%. \n\nIn comparison to its peers, Broach Lifecare's PE Ratio is significantly lower than that of Apollo Hospitals, which stands at 71.27, highlighting a substantial valuation gap. Additionally, while Broach Lifecare's PEG Ratio is at 0.00, indicating no growth expectations, other peers like Max Healthcare and Fortis Health are considered very expensive with PEG Ratios of 6.38 and 1.88, respectively. Despite a recent stock return of 3.75% over the past week, Broach Lifecare has underperformed the Sensex over the longer term, with a year-to-date decline of 16.67% compared to the Sensex's gain of 6.62%...."
      }
    ],
    "total": 21,
    "sid": "10039354",
    "stock_news_url": "https://uat-researchintel.adityabirlamoney.com/news/broach-lifecare-hospital-10039354"
  },
  "announcements": [
    {
      "caption": "Unaudited Standalone Financial Results For The Half Year Ended September 30 2025 Along With The Limited Review Report.",
      "datetime": "14-Nov-2025",
      "details": "Unaudited Standalone Financial Results for the half year ended on September 30 2025 along with Limited Review Report.",
      "source": "BSE"
    },
    {
      "caption": "Intimation For Appointment Of Secretarial Auditor For The FY 2025-26",
      "datetime": "14-Nov-2025",
      "details": "M/s. N R Shah & Co Company Secretaries Vadodara was appointed as Secretarial Auditor of the company for FY 2025-06 in pursuance of section 204 of the Companies Act 2013.",
      "source": "BSE"
    },
    {
      "caption": "Statement Of Deviation(S) Or Variation(S) Of Funds Raised Through Public Issue",
      "datetime": "14-Nov-2025",
      "details": "Statement of Deviation or Variation of funds raised through public issue for the period ended on September 30 2025",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

How has been the historical performance of Broach Lifecare?

2025-11-15 00:35:57

Answer: The historical performance of Broach Lifecare shows a mixed trend in financial metrics from March 2024 to March 2025. Breakdown: In the fiscal year ending March 2025, Broach Lifecare reported net sales of 3.18 Cr, an increase from 2.61 Cr in the previous year. Total operating income also rose to 3.18 Cr from 2.61 Cr, while total expenditure increased to 2.35 Cr from 1.58 Cr. Operating profit (PBDIT) decreased to 0.88 Cr from 1.03 Cr, leading to a decline in profit before tax to 0.72 Cr from 0.93 Cr. Consequently, profit after tax fell to 0.54 Cr from 0.70 Cr. The earnings per share (EPS) dropped to 0.89 from 1.57, reflecting a decrease in profitability. On the balance sheet, shareholder's funds grew to 9.36 Cr from 5.47 Cr, and total liabilities increased to 10.92 Cr from 5.72 Cr. The company reported a cash flow from financing activities of 4.00 Cr, consistent with the previous year, while cash fl...

Is Broach Lifecare overvalued or undervalued?

2025-11-07 08:14:28

As of 6 November 2025, Broach Lifecare's valuation grade has moved from very attractive to attractive, indicating a shift in market perception. The company is currently assessed as fairly valued. Key ratios include a PE Ratio of 20.23, an EV to EBITDA of 11.78, and a ROCE of 6.90%. In comparison to its peers, Broach Lifecare's PE Ratio is significantly lower than that of Apollo Hospitals, which stands at 71.27, highlighting a substantial valuation gap. Additionally, while Broach Lifecare's PEG Ratio is at 0.00, indicating no growth expectations, other peers like Max Healthcare and Fortis Health are considered very expensive with PEG Ratios of 6.38 and 1.88, respectively. Despite a recent stock return of 3.75% over the past week, Broach Lifecare has underperformed the Sensex over the longer term, with a year-to-date decline of 16.67% compared to the Sensex's gain of 6.62%....

View All News